Zobrazeno 1 - 10
of 262
pro vyhledávání: '"Xi Yang"'
Autor:
Yanqing Huang, Xiaoying Yang, Mengda Wei, Xi Yang, Zhenmin Yuan, Junjie Huang, Junren Wei, Lei Tian
Publikováno v:
Discover Oncology, Vol 15, Iss 1, Pp 1-18 (2024)
Abstract Background Gastric cancer (GC) is a malignant digestive tract tumor with a high recurrence rate and poor prognosis. Fucosylation is important in tumor glycosylation, in which the key enzyme is fucosyltransferase (FUT). FUT11 is a member of t
Externí odkaz:
https://doaj.org/article/7e4d680d5e384d8e813353ec8bcdbb20
Autor:
Ouwen Qiu, Jianyi Zhao, Zhonggang Shi, Huan Li, Siyuan Wang, Keman Liao, Minchao Tang, Jieqiong Xie, Xi Huang, Wenrui Zhang, Li Zhou, Xi Yang, Zhiyi Zhou, Lei Xu, Renhua Huang, Yifeng Miao, Yongming Qiu, Yingying Lin
Publikováno v:
iScience, Vol 27, Iss 5, Pp 109698- (2024)
Summary: Mounting evidence supports the role of neuroinflammation in radiation-induced brain injury (RIBI), a chronic disease characterized by delayed and progressive neurological impairment. Asparagine endopeptidase (AEP), also known as legumain (LG
Externí odkaz:
https://doaj.org/article/a52f89b739f34c6aabaf04c0a00f30eb
Autor:
Xiao-Yan Zhou, Chong-Xi Li, Jian-Bo Zhang, Jun-Ting Tang, Xi Yang, Rowida A. Albarmaqi, Yu-Ye Li, Yi-Qun Kuang
Publikováno v:
AIDS Research and Human Retroviruses. 38:884-889
To examine the association between human leukocyte antigen (HLA) and nevirapine (NVP)- and efavirenz (EFV)-induced cutaneous adverse reactions in human immunodeficiency virus (HIV) patients, we conducted a case-control study at our center consisting
Autor:
Tian-yue Liu, Chen-chen Hu, Chen-ying Han, Si-yi Mao, Wen-xin Zhang, Yi-ming Xu, Yuan-jie Sun, Dong-bo Jiang, Xi-yang Zhang, Jia-xing Zhang, Jing Wang, Xu-peng Qiao, Jing-yu Pan, Shu-ya Yang, Kun Yang
Publikováno v:
Biology Direct. 18
Background Colorectal cancer (CRC) is one of the most common malignant tumors of the digestive system, ranking third for morbidity and mortality worldwide. At present, no effective control method is available for this cancer type. In tumor cells, esp
Autor:
Gan Sun, Maolan Wu, Qianying Lv, Xi Yang, Junfeng Wu, Wenjing Tang, Rongxin Dai, Lina Zhou, Yuan Ding, Zhiyong Zhang, Yunfei An, Xuemei Tang, Xiangrong Zheng, Zhaoxia Wang, Li Sun, Yongmei Xie, Xiaodong Zhao, Hongqiang Du
Publikováno v:
Journal of Clinical Immunology.
Autor:
Gan Sun, Luyao Qiu, Lang Yu, Yunfei An, Yuan Ding, Lina Zhou, Junfeng Wu, Xi Yang, Zhiyong Zhang, Xuemei Tang, Huawei Xia, Lili Cao, Fuping You, Xiaodong Zhao, Hongqiang Du
Publikováno v:
Journal of Clinical Immunology. 42:798-810
Monogenic autoinflammatory diseases (mAIDs) are a heterogeneous group of diseases affecting primarily innate immunity, with various genetic causes. Genetic diagnosis of mAIDs can assist in the patient's management and therapy. However, a large number
Publikováno v:
International Immunopharmacology. 119:110216
Autor:
Xuemei Tang, Lu Yang, Xiuhong Xue, Xuemei Chen, Huawei Mao, Li Xu, Mo Wang, Junfeng Wu, Xi Yang, Xiaodong Zhao
Publikováno v:
Genes and Diseases, Vol 8, Iss 5, Pp 662-668 (2021)
Genes & Diseases
Genes & Diseases
CTLA4 deficiency and LRBA deficiency are a group disorders of immune dysregulation that affect CTLA4 pathway. The patients mainly present with autoimmunity, antibody deficiency and recurrent infections. Here we reported three Chinese patients with LR
Autor:
Xi Yang, Tiantian Guo, Liqing Zou, Zhengfei Zhu, Yida Li, Luxi Ye, Xiao Chu, Jianjiao Ni, Li Chu
Publikováno v:
Journal of Inflammation Research
Yida Li,1,2,* Liqing Zou,1,2,* Li Chu,1,2 Luxi Ye,1,2 Jianjiao Ni,1,2 Xiao Chu,1,2 Tiantian Guo,1,2 Xi Yang,1,2 Zhengfei Zhu1,2 1Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, Peopleâs Republic of Ch
Autor:
Xi-Yang Tang, Yan-Lu Xiong, Ya-Bo Zhao, Jie Yang, An-Ping Shi, Kai-Fu Zheng, Yu-Jian Liu, Chen Shu, Tao Jiang, Nan Ma, Jin-Bo Zhao
Publikováno v:
Frontiers in Immunology. 13
RationalLung cancer is the most common tumor worldwide, with the highest mortality rate and second highest incidence. Immunotherapy is one of the most important treatments for lung adenocarcinoma (LUAD); however, it has relatively low response rate a